The Great Peptide Debate, SpaceX's Lunar Mass Driver, AI Coming for Zuck's Job | Martin Shkreli & Max Marchione, Mitchell Green, Shane Hegde, Dr. Adam Oskowitz, Robin Vince, David Senra - TBPN Recap

Podcast: TBPN

Published: 2026-03-23

Duration: 10954

Guests: Martin Shkreli, Max Marchione, Mitchell Green, Shane Hegde, Dr. Adam Oskowitz, Robin Vince, David Senra

What Happened

Elon Musk's vision for a lunar mass driver involves constructing an electromagnetic launcher on the moon, potentially within 15 to 20 years. The mass driver could launch payloads using lunar resources like solar energy and basic materials. This ambitious project aims to overcome challenges such as lunar temperature fluctuations and the need for large-scale power infrastructure.

Martin Shkreli and Max Marchione engage in a heated debate over the growing popularity of peptides in health optimization. Shkreli criticizes the trend, attributing it to psychological factors and cautioning against non-FDA-approved use. Marchione, however, sees potential in peptides for wellness and advocates for updated regulations to allow safe and legal access.

Mitchell Green from Lead Edge Capital celebrates the closure of their $3.5 billion Fund 7, emphasizing its unique LP base of world-class executives. He underscores the resilience of the software industry, dismissing fears of a 'SaaS apocalypse' and highlighting the ongoing value of enterprise solutions.

Shane Hegde of Air announces their latest product release, including access to 50 AI models and usage-based pricing. He asserts that while AI is a powerful tool, it cannot replace the subjective nature of creative work, a sentiment encapsulated in their ad campaign tagline: 'AI will never smoke a cigarette with you.'

Dr. Adam Oskowitz from Doctronic introduces their AI-native care platform, offering 24/7 health consultations at $39 per visit. The platform's efficiency allows doctors to see more patients than traditional telehealth services, and a pilot program in Utah enables AI to renew prescriptions.

Robin Vince, CEO of BNY Mellon, outlines the bank's strategic focus on AI integration to enhance operations and services. The development of Eliza, an enterprise AI platform, supports over 125 AI-enabled solutions and fosters a culture of innovation through collaboration with Carnegie Mellon University.

David Senra reflects on his podcasting journey, drawing inspiration from historical entrepreneurs like Steve Jobs and Henry Ford. He stresses the importance of action over introspection, a philosophy shared by Elon Musk, who cautions against reinforcing negative neural pathways through excessive self-reflection.

Key Insights

• Elon Musk's lunar mass driver project aims to launch payloads using lunar resources, with a potential timeline of 15 to 20 years. Key challenges include constructing a reliable power infrastructure and dealing with lunar temperature fluctuations.
• Martin Shkreli is skeptical of the peptide trend, warning against the use of non-FDA-approved substances and emphasizing the need for a robust regulatory framework. Max Marchione argues for legalizing certain peptides to ensure safer access and reduce risks associated with the gray market.
• Lead Edge Capital's $3.5 billion Fund 7 attracts interest from a diverse LP base, highlighting the enduring value of enterprise software despite concerns of a 'SaaS apocalypse.' Mitchell Green emphasizes the importance of customer support and security in software companies.
• Doctronic's AI-native care platform, co-founded by Dr. Adam Oskowitz, offers 24/7 consultations across the U.S. The platform enhances doctor efficiency and includes a pilot program in Utah where AI can renew prescriptions, addressing telehealth's supply-demand mismatch.